Vitamin D Status and Associated Genetic Polymorphisms in a Cohort of UK Children with Non- Alcoholic Fatty Liver Disease

Total Page:16

File Type:pdf, Size:1020Kb

Vitamin D Status and Associated Genetic Polymorphisms in a Cohort of UK Children with Non- Alcoholic Fatty Liver Disease ORIGINALRESEARCH doi:10.1111/ijpo.12293 Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non- alcoholic fatty liver disease P. S. Gibson1,3, A. Quaglia2, A. Dhawan3,H.Wu1, S. Lanham-New1, K. H. Hart1, RESEARCH E. Fitzpatrick3,† and J. B. Moore1,4,† 1Department of Nutritional Sciences, School of Summary Biosciences and Medicine, Faculty of Health and Background: Vitamin D deficiency has been associated with non-alcoholic fatty Medical Sciences, University of Surrey, Guildford, UK; 2Institute of Liver Studies, King’s College liver disease (NAFLD). However, the role of polymorphisms determining vitamin D ORIGINAL London School of Medicine at King’s College status remains unknown. Hospital, London, UK; 3Pediatric Liver, GI and Objectives: The objectives of this study were to determine in UK children with Nutrition Centre, King’s College London School of Medicine at King’s College Hospital, London, biopsy-proven NAFLD (i) their vitamin D status throughout a 12-month period and UK; 4School of Food Science and Nutrition, (ii) interactions between key vitamin D-related genetic variants (nicotinamide adenine University of Leeds, Leeds, UK dinucleotide synthase-1/dehydrocholesterol reductase-7, vitamin D receptor, group-specific component, CYP2R1) and disease severity. †Joint senior authors. Methods: In 103 paediatric patients with NAFLD, serum 25-hydroxyvitamin D Address for correspondence: (25OHD) levels and genotypes were determined contemporaneously to liver biopsy Dr. J Bernadette Moore, University of and examined in relation to NAFLD activity score and fibrosis stage. Leeds, School of Food Science and Nutrition, West Yorkshire, Leeds Results: Only 19.2% of children had adequate vitamin D status; most had mean fi < À1 fi LS2 9JT, UK. 25OHD levels considered de cient ( 25 nmol·L , 25.5%) or insuf cient À1 E-mail: [email protected] (<50 nmol·L , 55.3%). Patients had significantly lower 25OHD levels in winter – À1 – Dr. E Fitzpatrick, Pediatric Liver, GI and months (95% CI: 22.7 31.2 nmol·L ) when compared with spring (30.5 À1 – À1 < Nutrition Centre, King’s College 42.1 nmol·L ; P = 0.0089), summer (36.3 47.2 nmol·L ; P 0.0001) and au- À1 London School of Medicine, London tumn (34.2–47.5 nmol·L ; P = 0.0003). Polymorphisms in the nicotinamide ade- SE5 9RS, UK. nine dinucleotide synthase-1/dehydrocholesterol reductase-7 (rs3829251, E-mail: emer.fi[email protected] rs12785878) and vitamin D receptor (rs2228570) genes were independently asso- ciated with increased steatosis; while a group-specific component variant (rs4588) Received 31 December 2017; revised 20 March was associated with increased inflammation in liver biopsies. 2018; accepted 4 April 2018 Conclusions: Children with NAFLD in the UK have particularly low winter vitamin D sta- tus, with vitamin D insufficiency prevalent throughout the year. Polymorphisms in the vita- min D metabolic pathway are associated with histological severity of paediatric NAFLD. Keywords: 25OHD, genotype, non-alcoholic fatty liver disease, vitamin D. Abbreviations: NAFLD, non-alcoholic fatty liver disease; 25OHD, 25- hydroxyvitamin D; BMI, body mass index; AST, aspartate transaminase; ALT, alanine transaminase; NAS, NAFLD activity score; SNPs, single nucleotide polymorphisms; NADSYN1, nicotinamide adenine dinucleotide synthase-1; NASH, non-alcoholic steatohepatitis; DHCR7, dehydrocholesterol reductase-7; GC, group-specific component; VDR, vitamin D receptor; PNPLA3, patatin-like phospholipase domain-containing protein 3 Introduction obese children, NAFLD is now the most common chronic liver disease in the paediatric population and A growing body of research suggests a relationship fast becoming the most common indication for liver between vitamin D deficiency and chronic liver dis- transplantation (1). Although transplantation for ease, in particular non-alcoholic fatty liver disease NAFLD in children is exceedingly rare, the histological (NAFLD). With prevalence estimated up to 80% in pattern of paediatric disease (type 2 non-alcoholic © 2018 The Authors. Pediatric Obesity published by John Wiley & Sons Ltd Pediatric Obesity 13, 433–441, July 2018 on behalf of World Obesity Federation This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. 434 | P. S. Gibson et al. steatohepatitis, NASH) is associated with more severe comprehensive clinical work up including abdominal disease and possibly with a rapid rate of progression (2). ultrasound, exclusion of viral hepatitis, Wilson disease Despite the high prevalence of NAFLD however, its and inborn errors of metabolism including lysosomal molecular pathogenesis remains only partially under- acid lyase deficiency. Liver biopsy was undertaken in stood and targeting those who are most likely to prog- the case of persistently abnormal liver function tests ress is difficult. The development and progression of (>2 upper limit of normal aspartate transaminase RESEARCH the disease are presumed to be multifactorial in nature [AST] or alanine transaminase [ALT]) with a duration and influenced by both genetic and nutritional factors over 6 months and/or an enlarged spleen (>1cm (3). Lifestyle change is the only proven effective treat- above upper limit of normal for age/height) on ultra- ment for paediatric NAFLD (4) and identifying those sound on two or more occasions suggesting signifi- at increased risk of progression may allow more cant liver injury. Liver biopsies were formalin-fixed targeted individualized therapy. Recent studies have and paraffin-embedded. Sections were stained with demonstrated that low vitamin D status associates haematoxylin and eosin, orcein, Perl’s and reticulin. with paediatric NAFLD independently of body mass Liver copper was also measured. Histological assess- ORIGINAL index (BMI) in Australian (5) and Italian (6) cohorts, ment was performed by a single hepato- raising the question of whether improvement in vita- histopathologist who was blinded to the patient’s clin- min D status through diet or supplementation may ical details and scored according to the Kleiner/Brunt be beneficial in some patients (7). system. Each biopsy was assigned a score for The most commonly used biomarker of vitamin D steatosis (0–3), lobular inflammation (0–3), hepatocyte status is 25-hydroxyvitamin D (25OHD), which is the ballooning (0–2) and fibrosis (0–4), and the NAFLD ac- most stable circulating form of vitamin D and reflects tivity score (NAS) was calculated. BMI was calculated both dietary intake and cutaneous synthesis (8). In by dividing weight, in kilograms by height, measured the UK, 25OHD status is highest in the summer and with a fixed stadiometer, in meters squared. lowest during winter and spring months. Vitamin D status has a strong hereditary component with dis- General biochemistry and measurement tinct sets of common gene variants, explaining some of 25-hydroxyvitamin D of the differences observed in vitamin D status be- tween different ethnic populations (9,10). Given the Liver enzymes and lipids were analysed using stan- possible association between low vitamin D status dard methods on the ADVIA 2400 analyser (Sie- and NAFLD, and the hereditary component of vitamin mens Healthcare Diagnostics, UK). Serum 25OHD D status, the aims of this study were to determine in a levels were measured only once due to low sample multi-ethnic cohort of children from the UK with volumes using a chemiluminescent immunoassay, biopsy-proven NAFLD (i) their 25OHD status and ex- the ADVIA Centaur Vitamin D Total Assay. Samples tent of vitamin D deficiency/insufficiency throughout were coded, and the researcher was blinded to clin- a given 12-month period and (ii) interactions between ical details. The sensitivity of the assay is estimated key polymorphisms related to vitamin D metabolism to range from 10 nmol·LÀ1 to 375 nmol·LÀ1, while and NAFLD disease severity. the inter-assay variation was 4.2–11.9% and the percentage of cross reactivity with vitamin D2 and fi Methods D3 was 1.1%. We used thresholds de ned by the Study design and patients UK Department of Health (11) and the US Institute of Medicine (8) for assessing vitamin D status; This observational study received ethical approval 25OHD concentrations below 25 nmol·LÀ1 were from the UK National Research Ethics Service (09/ considered deficient and below 50 nmol·LÀ1 as in- H0808/15) and was conducted according to the Hel- sufficient, respectively. sinki declaration. Anonymised clinical data were ex- amined from patients who had attended a tertiary Genotyping paediatric liver centre (King’s College Hospital, London, UK) between March 2001 and July 2013; Eight candidate polymorphisms were selected based who had suspected NAFLD confirmed by biopsy on their established influence on vitamin D status and had buffy coat samples available. All patients in- (9,10,12) and/or liver disease (13,14). The variants in- cluded were less than 19 years of age at sample col- cluded two intronic single nucleotide polymorphisms lection. Patients were excluded if taking vitamin D (SNPs) (rs12785878 and rs3829251) in the nicotin- supplementation or if NAFLD was not the primary liver amide adenine dinucleotide (NAD) synthetase-1 diagnosis. Other liver diseases were ruled out through (NADSYN1) gene, responsible for the final step in the Pediatric Obesity 13, 433–441, July 2018 © 2018 The Authors. Pediatric Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation Vitamin D-related polymorphisms in NAFLD | 435 biosynthesis of NAD. The NADSYN1 gene is located August values were used for all comparisons. We immediately proximal to the dehydrocholesterol have estimated that for this cohort (n = 103), consid- reductase-7 (DHCR7) gene on chromosome 11q12, ering an α error = 0.05 and SD = 19.33 nmol·LÀ1 in which encodes the rate-limiting enzyme responsible serum vitamin D levels, we had a power of >80% to for the reduction of 7-dehydrocholesterol to choles- detect a difference of 5.34 nmol·LÀ1 within this group.
Recommended publications
  • Snps Related to Vitamin D and Breast Cancer Risk
    Huss et al. Breast Cancer Research (2018) 20:1 DOI 10.1186/s13058-017-0925-3 RESEARCHARTICLE Open Access SNPs related to vitamin D and breast cancer risk: a case-control study Linnea Huss1* , Salma Tunå Butt1, Peter Almgren 2, Signe Borgquist3,4, Jasmine Brandt1, Asta Försti5,6, Olle Melander2 and Jonas Manjer1 Abstract Background: It has been suggested that vitamin D might protect from breast cancer, although studies on levels of vitamin D in association with breast cancer have been inconsistent. Genome-wide association studies (GWASs) have identified several single-nucleotide polymorphisms (SNPs) to be associated with vitamin D. The aim of this study was to investigate such vitamin D-SNP associations in relation to subsequent breast cancer risk. A first step included verification of these SNPs as determinants of vitamin D levels. Methods: The Malmö Diet and Cancer Study included 17,035 women in a prospective cohort. Genotyping was performed and was successful in 4058 nonrelated women from this cohort in which 865 were diagnosed with breast cancer. Levels of vitamin D (25-hydroxyvitamin D) were available for 700 of the breast cancer cases and 643 of unaffected control subjects. SNPs previously associated with vitamin D in GWASs were identified. Logistic regression analyses yielding ORs with 95% CIs were performed to investigate selected SNPs in relation to low levels of vitamin D (below median) as well as to the risk of breast cancer. Results: The majority of SNPs previously associated with levels of vitamin D showed a statistically significant association with circulating vitamin D levels. Heterozygotes of one SNP (rs12239582) were found to have a statistically significant association with a low risk of breast cancer (OR 0.82, 95% CI 0.68–0.99), and minor homozygotes of the same SNP were found to have a tendency towards a low risk of being in the group with low vitamin D levels (OR 0.72, 95% CI 0.52–1.00).
    [Show full text]
  • Nicotinamide Riboside Kinases Display Redundancy in Mediating Nicotinamide Mononucleotide and Nicotinamide Riboside Metabolism in Skeletal Muscle Cells
    Original Article Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells Rachel S. Fletcher 1,2, Joanna Ratajczak 3,4, Craig L. Doig 1,2, Lucy A. Oakey 2, Rebecca Callingham 5, Gabriella Da Silva Xavier 5, Antje Garten 1,6, Yasir S. Elhassan 1,2, Philip Redpath 7, Marie E. Migaud 7, Andrew Philp 8, Charles Brenner 9, Carles Canto 3,4, Gareth G. Lavery 1,2,* ABSTRACT þ Objective: Augmenting nicotinamide adenine dinucleotide (NAD ) availability may protect skeletal muscle from age-related metabolic decline. þ Dietary supplementation of NAD precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) appear efficacious in elevating þ þ muscle NAD . Here we sought to identify the pathways skeletal muscle cells utilize to synthesize NAD from NMN and NR and provide insight into mechanisms of muscle metabolic homeostasis. þ Methods: We exploited expression profiling of muscle NAD biosynthetic pathways, single and double nicotinamide riboside kinase 1/2 (NRK1/ þ 2) loss-of-function mice, and pharmacological inhibition of muscle NAD recycling to evaluate NMN and NR utilization. Results: Skeletal muscle cells primarily rely on nicotinamide phosphoribosyltransferase (NAMPT), NRK1, and NRK2 for salvage biosynthesis of þ þ NAD . NAMPT inhibition depletes muscle NAD availability and can be rescued by NR and NMN as the preferred precursors for elevating muscle þ cell NAD in a pathway that depends on NRK1 and NRK2. Nrk2 knockout mice develop normally and show subtle alterations to their NADþ metabolome and expression of related genes. NRK1, NRK2, and double KO myotubes revealed redundancy in the NRK dependent þ metabolism of NR to NAD .
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • Open Data for Differential Network Analysis in Glioma
    International Journal of Molecular Sciences Article Open Data for Differential Network Analysis in Glioma , Claire Jean-Quartier * y , Fleur Jeanquartier y and Andreas Holzinger Holzinger Group HCI-KDD, Institute for Medical Informatics, Statistics and Documentation, Medical University Graz, Auenbruggerplatz 2/V, 8036 Graz, Austria; [email protected] (F.J.); [email protected] (A.H.) * Correspondence: [email protected] These authors contributed equally to this work. y Received: 27 October 2019; Accepted: 3 January 2020; Published: 15 January 2020 Abstract: The complexity of cancer diseases demands bioinformatic techniques and translational research based on big data and personalized medicine. Open data enables researchers to accelerate cancer studies, save resources and foster collaboration. Several tools and programming approaches are available for analyzing data, including annotation, clustering, comparison and extrapolation, merging, enrichment, functional association and statistics. We exploit openly available data via cancer gene expression analysis, we apply refinement as well as enrichment analysis via gene ontology and conclude with graph-based visualization of involved protein interaction networks as a basis for signaling. The different databases allowed for the construction of huge networks or specified ones consisting of high-confidence interactions only. Several genes associated to glioma were isolated via a network analysis from top hub nodes as well as from an outlier analysis. The latter approach highlights a mitogen-activated protein kinase next to a member of histondeacetylases and a protein phosphatase as genes uncommonly associated with glioma. Cluster analysis from top hub nodes lists several identified glioma-associated gene products to function within protein complexes, including epidermal growth factors as well as cell cycle proteins or RAS proto-oncogenes.
    [Show full text]
  • Metabolic Tracing of NAD Precursors Using Strategically Labelled Isotopes of NMN
    A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy Metabolic tracing of NAD+ precursors using strategically labelled isotopes of NMN by Lynn-Jee Kim Supervisors Dr. Lindsay E. Wu (Primary) Prof. David A. Sinclair (Joint-Primary) Dr. Lake-Ee Quek (Co-supervisor) School of Medical Sciences Faculty of Medicine Thesis/Dissertation Sheet Surname/Family Name: Kim Given Name/s: Lynn-Jee Abbreviation for degree as give in PhD the University calendar: Faculty: Faculty of Medicine School: School of Medical Sciences + Thesis Title: Metabolic tracing of NAD precursors using strategically labelled isotopes of NMN Abstract 350 words maximum: (PLEASE TYPE) Nicotinamide adenine dinucleotide (NAD+) is an important cofactor and substrate for hundreds of cellular processes involved in redox homeostasis, DNA damage repair and the stress response. NAD+ declines with biological ageing and in age-related diseases such as diabetes and strategies to restore intracellular NAD+ levels are emerging as a promising strategy to protect against metabolic dysfunction, treat age-related conditions and promote healthspan and longevity. One of the most effective ways to increase NAD+ is through pharmacological supplementation with NAD+ precursors such as nicotinamide mononucleotide (NMN) which can be orally delivered. Long term administration of NMN in mice mitigates age-related physiological decline and alleviates the pathophysiologies associated with a high fat diet- and age-induced diabetes. Despite such efforts, there are certain aspects of NMN metabolism that are poorly understood. In this thesis, the mechanisms involved in the utilisation and transport of orally administered NMN were investigated using strategically labelled isotopes of NMN and mass spectrometry.
    [Show full text]
  • Polymorphisms in GC and NADSYN1 Genes Are Associated with Vitamin
    Foucan et al. BMC Endocrine Disorders 2013, 13:36 http://www.biomedcentral.com/1472-6823/13/36 RESEARCH ARTICLE Open Access Polymorphisms in GC and NADSYN1 Genes are associated with vitamin D status and metabolic profile in Non-diabetic adults Lydia Foucan1,2,9*, Fritz-Line Vélayoudom-Céphise1,3, Laurent Larifla1, Christophe Armand1, Jacqueline Deloumeaux1, Cedric Fagour1, Jean Plumasseau4, Marie-Line Portlis5, Longjian Liu6, Fabrice Bonnet7 and Jacques Ducros8 Abstract Background: Our aim was to assess the associations between vitamin D (vitD) status, metabolic profile and polymorphisms in genes involved in the transport (Group-Component: GC) and the hydroxylation (NAD synthetase 1: NADSYN1) of 25 hydroxyvitamin D (25(OH)D) in non-diabetic individuals. Methods: We conducted a cross-sectional study with 323 individuals recruited from the Health Center of Guadeloupe, France. The rs2282679 T > G and rs2298849 T > C in GC and rs12785878 G > T in NADSYN1 were genotyped. Results: Mean age was 46(range 18–86) years. 57% of participants had vitD insufficiency, 8% had vitD deficiency, 61% were overweight and 58% had dyslipidemia. A higher frequency of overweight was noted in women carrying rs2298849T allele v CC carriers (71% v 50%; P = 0.035). The rs2282679G allele was associated with increased risks of vitD deficiency and vitD insufficiency (OR =3.53, P = 0.008, OR = 2.34, P = 0.02 respectively). The rs2298849 TT genotype was associated with vitD deficiency and overweight (OR =3.4, P = 0.004 and OR = 1.76, P = 0.04 respectively) and the rs12785878 GG genotype with vitD insufficiency and dyslipidemia (OR = 1.80, P = 0.01 and OR = 1.72, P = 0.03 respectively).
    [Show full text]
  • Prioritization of Variants for Investigation of Genotype-Directed Nutrition in Human Superpopulations
    International Journal of Molecular Sciences Article Prioritization of Variants for Investigation of Genotype-Directed Nutrition in Human Superpopulations 1, 1, 1 Pascal D. Nilsson y , Jacklyn M. Newsome y , Henry M. Santos and Martin R. Schiller 1,2,* 1 Nevada Institute of Personalized Medicine and School of Life Sciences, University of Nevada Las Vegas, Las Vegas, NV 89154-4004, USA 2 Food Genes and Me LLC, 929 Via Doccia Court. Henderson, NV 89011, USA * Correspondence: [email protected] These authors contributed equally to this manuscript. y Received: 14 May 2019; Accepted: 16 July 2019; Published: 18 July 2019 Abstract: Dietary guidelines recommended by key health agencies are generally designed for a global population. However, ethnicity affects human disease and environment-gene interactions, including nutrient intake. Historically, isolated human populations with different genetic backgrounds have adapted to distinct environments with varying food sources. Ethnicity is relevant to the interaction of food intake with genes and disease susceptibility; yet major health agencies generally do not recommend food and nutrients codified by population genotypes and their frequencies. In this paper, we have consolidated published nutrigenetic variants and examine their frequencies in human superpopulations to prioritize these variants for future investigation of population-specific genotype-directed nutrition. The nutrients consumed by individuals interact with their genome and may alter disease risk. Herein, we searched the literature, designed a data model, and manually curated hundreds of papers. The resulting database houses 101 variants that reached significance (p < 0.05), from 35 population studies. Nutrigenetic variants associated with modified nutrient intake have the potential to reduce the risk of colorectal cancer, obesity, metabolic syndrome, type 2 diabetes, and several other diseases.
    [Show full text]
  • The Role of Natural Selection in Human Evolution – Insights from Latin America
    Genetics and Molecular Biology, 39, 3, 302-311 (2016) Copyright © 2016, Sociedade Brasileira de Genética. Printed in Brazil DOI: http://dx.doi.org/10.1590/1678-4685-GMB-2016-0020 Review Article The role of natural selection in human evolution – insights from Latin America Francisco M. Salzano1 1Departamento de Genética, Instituto de Biociências, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Abstract A brief introduction considering Darwin’s work, the evolutionary synthesis, and the scientific biological field around the 1970s and subsequently, with the molecular revolution, was followed by selected examples of recent investiga- tions dealing with the selection-drift controversy. The studies surveyed included the comparison between essential genes in humans and mice, selection in Africa and Europe, and the possible reasons why females in humans remain healthy and productive after menopause, in contrast with what happens in the great apes. At the end, selected exam- ples of investigations performed in Latin America, related to the action of selection for muscle performance, acetylation of xenobiotics, high altitude and tropical forest adaptations were considered. Despite dissenting views, the influence of positive selection in a considerable portion of the human genome cannot presently be dismissed. Keywords: natural selection, human evolution, population genetics, human adaptation, history of genetics. Received: February 10, 2016; Accepted: May 8, 2016. History deniably indicated that we had derived from
    [Show full text]
  • Cell Culture-Based Profiling Across Mammals Reveals DNA Repair And
    1 Cell culture-based profiling across mammals reveals 2 DNA repair and metabolism as determinants of 3 species longevity 4 5 Siming Ma1, Akhil Upneja1, Andrzej Galecki2,3, Yi-Miau Tsai2, Charles F. Burant4, Sasha 6 Raskind4, Quanwei Zhang5, Zhengdong D. Zhang5, Andrei Seluanov6, Vera Gorbunova6, 7 Clary B. Clish7, Richard A. Miller2, Vadim N. Gladyshev1* 8 9 1 Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard 10 Medical School, Boston, MA, 02115, USA 11 2 Department of Pathology and Geriatrics Center, University of Michigan Medical School, 12 Ann Arbor, MI 48109, USA 13 3 Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, 14 MI 48109, USA 15 4 Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 16 48109, USA 17 5 Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10128, USA 18 6 Department of Biology, University of Rochester, Rochester, NY 14627, USA 19 7 Broad Institute, Cambridge, MA 02142, US 20 21 * corresponding author: Vadim N. Gladyshev ([email protected]) 22 ABSTRACT 23 Mammalian lifespan differs by >100-fold, but the mechanisms associated with such 24 longevity differences are not understood. Here, we conducted a study on primary skin 25 fibroblasts isolated from 16 species of mammals and maintained under identical cell culture 26 conditions. We developed a pipeline for obtaining species-specific ortholog sequences, 27 profiled gene expression by RNA-seq and small molecules by metabolite profiling, and 28 identified genes and metabolites correlating with species longevity. Cells from longer-lived 29 species up-regulated genes involved in DNA repair and glucose metabolism, down-regulated 30 proteolysis and protein transport, and showed high levels of amino acids but low levels of 31 lysophosphatidylcholine and lysophosphatidylethanolamine.
    [Show full text]
  • Genome-Wide Association Study of Vitamin D Levels in Children: Replication in the Western Australian Pregnancy Cohort (Raine) Study
    Genes and Immunity (2014) 15, 578–583 © 2014 Macmillan Publishers Limited All rights reserved 1466-4879/14 www.nature.com/gene SHORT COMMUNICATION Genome-wide association study of vitamin D levels in children: replication in the Western Australian Pregnancy Cohort (Raine) study D Anderson1, BJ Holt1, CE Pennell2, PG Holt1, PH Hart1 and JM Blackwell1 This genome-wide association study (GWAS) utilises data from the Western Australian Pregnancy Cohort (Raine) Study for 25- hydroxyvitamin D (25(OH)D) levels measured in blood collected at age 6 years (n = 673) and at age 14 years (n = 1140). Replication of significantly associated genes from previous GWASs was found for both ages. Genome-wide significant associations were found both at age 6 and 14 with single nucleotide polymorphisms (SNPs) on chromosome 11p15 in PDE3B/CYP2R1 (age 6: rs1007392, P = 3.9 × 10 − 8; age14: rs11023332, P = 2.2 × 10 − 10) and on chromosome 4q13 in GC (age 6: rs17467825, P = 4.2 × 10 − 9; age14: rs1155563; P = 3.9 × 10 − 9). In addition, a novel association was observed at age 6 with SNPs on chromosome 7p15 near NPY (age 6: rs156299, P = 1.3 × 10 − 6) that could be of functional interest in highlighting alternative pathways for vitamin D metabolism in this age group and merits further analysis in other cohort studies. Genes and Immunity (2014) 15, 578–583; doi:10.1038/gene.2014.52; published online 11 September 2014 INTRODUCTION RESULTS AND DISCUSSION In humans, vitamin D is obtained primarily through exposure to Descriptive statistics of the study participants are shown in ultraviolet B radiation from sunlight and secondarily through a Table 1.
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • NAD Metabolism in Health and Disease
    Review TRENDS in Biochemical Sciences Vol.32 No.1 NAD+ metabolism in health and disease Peter Belenky, Katrina L. Bogan and Charles Brenner* Departments of Genetics and of Biochemistry and Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03756, USA Nicotinamide adenine dinucleotide (NAD+) is both a developing the nutritional deficiency pellagra unless their coenzyme for hydride-transfer enzymes and a substrate diet is supplemented with one of the classical vitamin for NAD+-consuming enzymes, which include ADP- precursors of NAD+, nicotinic acid (Na) or nicotinamide ribose transferases, poly(ADP-ribose) polymerases, (Nam), which are collectively termed niacin. As shown in cADP-ribose synthases and sirtuins. Recent results Figure 2, the salvage pathways for the two niacins are establish protective roles for NAD+ that might be applic- encoded by different genes and, thus, might not be able therapeutically to prevent neurodegenerative con- expressed equally in all vertebrate tissues. The blood– ditions and to fight Candida glabrata infection. In borne bacterium Haemophilus influenza can not synthe- addition, the contribution that NAD+ metabolism makes size NAD+ de novo or salvage niacins (see Glossary). to lifespan extension in model systems indicates that Instead, it depends on uptake of nicotinamide riboside therapies to boost NAD+ might promote some of the (NR) and a bacterial pathway that converts NR to NAD+ beneficial effects of calorie restriction. Nicotinamide by phosphorylation and subsequent adenylylation [1]. riboside, the recently discovered nucleoside precursor Recently, it has become apparent that fungi and verte- of NAD+ in eukaryotic systems, might have advantages brates encode eukaryotic NR kinases (Nrk isozymes) to as a therapy to elevate NAD+ without inhibiting sirtuins, salvage NR, a third vitamin precursor of NAD+, which which is associated with high-dose nicotinamide, or occurs in milk [2].
    [Show full text]